Will be interesting to see how Regal vote...
Surely, with such a large stake themselves, they can see the need for some changes at the top too.
In my opinion, if we could get rid of DD and replace him with a merit-based CEO, we would get an immediate share price boost.
At this point, WGO is receiving a big management-risk discount from the market.
Ironically, the best way for both Donald and Duncan to maximise their own wealth might be to step away from running the company.
- Forums
- ASX - By Stock
- WGO
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-45
-
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online